Depression and Anxiety Trial, Recruiting (NCT05239780)

Depression and Anxiety Trial, Recruiting NCT05239780 Sponsor: Icahn School of Medicine at Mount Sinai Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT05239780 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults of any age who are already being considered for invasive brain monitoring as part of their epilepsy care

Who may not be able to join:

Adults who are over 80 years old, due to concerns about age-related changes in thinking and memory
Anyone under the age of 18, because the part of the brain being studied (the frontal lobe) is still developing during adolescence and works differently in younger people compared to adults

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ignacio Saez, Ph.D., Icahn School of Medicine at Mount Sinai

Phone: (661) 772-6200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05239780

Sponsor: Icahn School of Medicine at Mount Sinai

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: (661) 772-6200

More information: https://clinicaltrials.gov/study/NCT05239780

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults of any age who are already being considered for invasive brain monitoring as part of their epilepsy care

Who may not be able to join:

Adults who are over 80 years old, due to concerns about age-related changes in thinking and memory
Anyone under the age of 18, because the part of the brain being studied (the frontal lobe) is still developing during adolescence and works differently in younger people compared to adults

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Icahn School of Medicine at Mount Sinai

Registry

ClinicalTrials.gov

Start date

6 October 2021

Est. completion

31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Gambling Task

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov